Lake Street Advisors Group, LLC Finch Therapeutics Group, Inc. Transaction History

Lake Street Advisors Group, LLC

  • $2.11 Billion
  • Q1 2024

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Feb 15, 2022
BUY
$8.95 - $16.88 $921,321 - $1.74 Million
102,941 Added 16.18%
739,136 $7.37 Million
Q3 2021

Nov 15, 2021
BUY
$12.2 - $16.75 $7.76 Million - $10.7 Million
636,195 New
636,195 $8.27 Million

About Finch Therapeutics Group, Inc.

FNCH Quotes by TradingView
  • Ticker FNCH
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 47,688,400
  • Market Cap $63.4M
  • Description
  • Finch Therapeutics Group, Inc., a clinical-stage microbiome therapeutics company, develops a novel class of orally administered biological drugs in the United States. The company's lead candidate is CP101, an orally administered microbiome capsule that is in Phase 3 clinical trial for the treatment of patients with recurrent Clostridioides diffi...
More about FNCH
Track This Portfolio

Track Lake Street Advisors Group, LLC Portfolio

Follow Lake Street Advisors Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Lake Street Advisors Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Lake Street Advisors Group, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email